Express Pharma

Biological E seeks DCGI’s nod for phase-III trial of Corbevax as booster dose in those vaccinated with Covishield or Covaxin

Currently, phase-II/III clinical trials of the second indigenously developed Corbevax is underway and the results are likely to be declared this month